How I explore... The absolute cardiovascular risk at 10 years: From Framingham 1998 to SCORE 2003;Comment j'explore... Le risque cardio-vasculaire absolu à 10 ans: De Framingham 1998 à SCORE 2003

Revue Medicale de Liege

Volumn 59, Issue 7-8, 2004, Pages 460-466

  Scheen, A J ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Cardiovascular risk; Coronary heart disease; Death prediction; Prevention; SCORE; Stroke

Indexed keywords

ATHEROSCLEROSIS; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HIGH RISK POPULATION; HUMAN; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PREDICTION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; HUMANS; MATHEMATICS; RISK ASSESSMENT;

EID: 4544374906     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Naghavi M, Libby P Falk E, et al. - From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies. Circulation, 2003, 108, 1664-1672 (part I) and 1772-1778 (part II).
2. Naghavi M, Libby P Falk E, et al. - From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies. Circulation, 2003, 108, 1664-1672 (part I) and 1772-1778 (part II).
3. Pyörälä K, De Backer G, Graham I, et al. - Prévention de la maladie coronarienne en pratique clinique: résumé pour les cliniciens. Rev Med Liège, 1996, 51, 654-660.
4. Dawber TR, Kannel W, Revotskie N, et al. - The epidemiology of coronary heart disease - the Framingham Enquiry. Proc Roy Soc Med, 1962, 55, 265-271.
5. Anderson KM, Wilson PW, Odell PM, et al. - An updated coronary risk profile. A statement for health professionals. Circulation, 1991, 83, 356-362.
6. Scheen AJ, Lefèbvre PJ, Kulbertus H. - Comment je préviens... Les maladies cardio-vasculaires par une approche pharmacologique combinée: y a-t-il place pour une «polypill»? Rev Med Liège, 2003, 57, 527-533.
7. Task Force Report. - Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J, 1998, 19, 1434-1503.
8. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. - Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ, 2000, 320, 705-708.
9. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. - Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
10. Johannesson M. - At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention? Eur Heart J, 2001, 22, 919-925.
11. Scheen AJ. - La mesure de l'efficacité thérapeutique, étape essentielle dans la médecine factuelle. Rev Med Liège, 2000, 55, 206-210.
12. Scheen AJ. - Pharmaco-économie des médicaments hypolipidémiants: analyse des facteurs influençant le rapport coût/efficacité. Rev Med Liège, 1998, 53, 270-275.
13. Ducobu J, Scheen AJ. - Les recommandations du Belgian Lipid Club pour le diagnostic et le traitement des hyperlipidémies: résumé pour le praticien. Rev Med Liège, 2000, 55, 360-366.
14. Pyörälä K. - Assessment of coronary heart disease risk in populations with different levels of risk. Eur Heart J, 2000, 21, 348-350.
15. Conroy RM, Pyörälä K, Fitzgerald AP, et al. - on behalf of the SCORE project group. - Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003, 24, 987-1003.
16. DeBacker G, Ambrosioni E, Borch-Johnsen K, et al. - Executive Summary. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on cardiovascular disease prevention in clinical practice. Eur Heart J, 2003, 24, 1600-1609.
17. Scheen AJ, Rorive G, Kulbertus H. - Comment j'explore... le risque coronarien individuel extrapolé à 10 ans. Rev Med Liège, 1999, 54, 118-121.
18. DeBacker. G, Ambrosoni E, Borch-Johnsen K, et al. - European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab, 2003, 10 (supp 1), S1-S78
19. Anonymous (The BIRNH Study Group). - Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium. 1. Design and methodology. Nutrition and health: a interuniversity study. Acta Cardiol, 1984, 39, 285-292.
20. Kornitzer M, Bara L. - Clinical and anthropometric data, blood chemistry and nutritional patterns in the Belgian population according to age and sex. For the B.I.R.N.H. Study Group. Acta Cardiol, 1989, 44, 101-144.
21. Paquot N, Scheen A.J. - Prévention cardio-vasculaire chez le patient diabétique de type 2. Rev Med Liège, 2003, 58, 271-274.
22. Fuller JH, Stevens LK, Wang SL. - Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia, 2001, 44 (Suppl 2), S54-S64.
23. Scheen AJ, Kulbertus H. - Prévention cardio-vasculaire par les statines: faut-il encore doser le cholestérol? Rev Med Liège, 2003, 58, 191-197.
24. D'Agostino RB, Russel MW, Huse DM, et al. - Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J, 2000, 139, 272-281.
25. Anonymous. - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 2002, 106, 3143-3421.
26. Menotti A, Lanti M, Puddu PE, et al. - Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart, 2000, 84, 238-244.
27. De Bacquer D, De Backer G. - Calibration of the SCORE risk chart for fatal cardiovascular events to Belgian Characteristics. A Belgian risk chart. Personal communication at the National Task Force meeting, July 8, 2004.